Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493727 · ClinicalTrials.gov registry record · NA
Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00493727 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 15 participants.
The verdict
NCT00493727, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The study will look at the effect of 30 days of treatment of 15 diabetics with proteinuria with N-acetylcysteine ( Mucomyst ) at a dose of 1 gm twice a day by mouth. The primary outcome that will be measured is change in the oxidant stress as measurable by changes in the serum level of isoprostane, Glutathione peroxidase, aconitase and Total oxidant stress. Secondary outcomes measured will be changes in proteinuria and kidney function as measured by spot urine pr/cr and estimated GFR by MDRD formula.
Interventions
- DRUG N-acetylcysteine(Mucomyst)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00493727
The ClinicalTrials.gov registry entry for NCT00493727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N-acetylcysteine(Mucomyst) is the first listed.
NCT00493727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00493727 about?
NCT00493727 is a clinical study titled "Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria". The study will look at the effect of 30 days of treatment of 15 diabetics with proteinuria with N-acetylcysteine ( Mucomyst ) at a dose of 1 gm twice a day by mouth. The primary outcome that will be measured is change in the oxidant stress as measurable by changes in the serum level of isoprostane, ...
What is the current status of trial NCT00493727?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2006-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00493727?
The interventions under investigation include: N-acetylcysteine(Mucomyst) (DRUG).
Who is sponsoring clinical trial NCT00493727?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.